S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(0.43%) $10.74
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Yuyu Pharma, Inc. [000220.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated17 May 2024 @ 02:30

-0.20% KRW 5 050.00

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 02:30):

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants...

Stats
Today's Volume 407 951
Average Volume 221 831
Market Cap 81.72B
EPS KRW0 ( 2023-09-30 )
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW10.34 (0.20%)

Volume Correlation

Long: 0.13 (neutral)
Short: 0.78 (moderate)
Signal:(45.981) Neutral

Yuyu Pharma, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuyu Pharma, Inc. Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.45
( neutral )
The country flag 0.06
( neutral )
The country flag 0.17
( neutral )
The country flag 0.51
( weak )
The country flag 0.40
( neutral )

Yuyu Pharma, Inc. Financials

Annual 2023
Revenue: KRW137.21B
Gross Profit: KRW46.51B (33.89 %)
EPS: KRW-441.41
FY 2023
Revenue: KRW137.21B
Gross Profit: KRW46.51B (33.89 %)
EPS: KRW-441.41
FY 2022
Revenue: KRW138.88B
Gross Profit: KRW53.31B (38.39 %)
EPS: KRW-266.90
FY 2021
Revenue: KRW115.66B
Gross Profit: KRW45.34B (39.20 %)
EPS: KRW-21.10

Financial Reports:

No articles found.

Yuyu Pharma, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Yuyu Pharma, Inc.

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators